• 1
    Bazzoni, F. & Beutler, B. (1995) How do tumor necrosis factor receptors work? Journal of Inflammation, 45, 221 238.
  • 2
    Brockhaus, M., Schoenfeld, H.J., Schlaeger, E.J., Hunziker, W., Lesslauer, W., Loetscher, H. (1990) Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proceedings of the National Academy of Sciences of the United States of America, 87, 3127 3131.
  • 3
    Carter, A., Haddad, N., Draxler, I., Israeli, E., Raz, B., Rowe, J.M. (1996) Expression and role in growth regulation of tumour necrosis factor receptors p55 and p75 in acute myeloblastic leukaemia cells. British Journal of Haematology, 92, 116 126.
  • 4
    Carter, A., Haddad, N., Draxler, I., Israeli, E., Raz, B., Tatarsky, I. (1994) Respective effects of soluble interleukin-1 receptor and tumour necrosis factor receptor on IL-1 and TNF-alpha-induced DNA synthesis of common acute lymphoblastic leukaemia blasts in vitro. British Journal of Haematology, 86, 22 29.
  • 5
    Cox, D.R. (1972) Regression models and life-tables. Journal of the Royal Statistical Society, B, 34, 187 220.
  • 6
    Delwel, R., Van Buitenen, C., Lowenberg, B., Touw, I. (1992) Involvement of tumor necrosis factor (TNF) receptors p55 and p75 in TNF responses of acute myeloid leukemia blasts in vitro. Blood, 80, 1798 1803.
  • 7
    Dembic, Z., Loetscher, H., Gubler, V., Pan, Y.C., Lahm, H.W., Gentz, R., Brockhaus, M., Lesslauer, W. (1990) Two human TNF receptors have similar extracellular but distinct intracellular domain sequences. Cytokine, 22, 231 237.
  • 8
    Elbaz, O., Budel, L.M., Hoogerbrugge, H., Touw, I.P., Delwel, R., Mahmoud, L.A., Lowenberg, B. (1991a) Tumor necrosis factor regulates the expression of granulocyte-macrophage colony-stimulating factor and interleukin-3 receptors on human acute myeloid leukemia cells. Blood, 77, 989 995.
  • 9
    Elbaz, O., Budel, L.M., Hoogerbrugge, H., Touw, I.P., Delwel, R., Mahmoud, L.A., Lowenberg, B. (1991b) Tumor necrosis factor (TNF) down regulates G-CSF receptor expression on human acute myeloid leukemia (AML) cells and granulocytes. Journal of Clinical Investigation, 87, 838 841.
  • 10
    Gruss, H.J. & Dower, S.K. (1995) The TNF ligand superfamily and its relevance for human diseases. Cytokines and Molecular Therapy, 1, 75 105.
  • 11
    Heaney, M.L. & Golde, D.W. (1996) Soluble cytokine receptors. Blood, 87, 847 857.
  • 12
    Heller, R.A., Song, K., Onasch, M.A., Fischer, W.H., Chand, D., Ringold, D.M. (1990) Complementary DNA cloning of a receptor for human necrosis factor and demonstration of a shed form of the receptor. Proceedings of the National Academy of Sciences of the United States of America, 87, 6151 6155.
  • 13
    Higuchi, M. & Aggarwal, B.B. (1994) TNF induces internalization of the p60 receptor and shedding of the p80 receptor. Journal of Immunology, 152, 3550 3558.
  • 14
    Hoang, T., Levy, B., Onetto, N., Haman, A., Rodriguez-Cimadevilla, J.C. (1989) Tumor necrosis factor alpha stimulates the growth of the clonogenic cells of acute myeloblastic leukemia in synergy with granulocyte/macrophage colony-stimulating factor. Journal of Experimental Medicine, 170, 15 26.
  • 15
    Hsu, H., Xiong, J., Goeddel, D.V. (1995) The TNF receptor 1-associated protein TRADD signals cell death and NF-kappaB activation. Cell, 81, 495 504.
  • 16
    Hwang, C., Gatanaga, M., Granger, G., Gatanaga, T. (1993) Mechanism of release of soluble forms of tumor necrosis factor/lymphotoxin receptors by phorbol myristate acetate-stimulated human THP-1 cells in vitro. Journal of Immunology, 151, 5631 5638.
  • 17
    Kaplan, E.L. & Meier, P. (1958) Non-parametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457 481.
  • 18
    Khoury, E., André, C., Pontvert-Delucq, S., Drenou, B., Baillou, C., Guigon, M., Najman, A., Lemoine, F.M. (1994) Tumor necrosis factor a (TNFα) downregulates c-kit proto-oncogene product expression in normal and acute myeloid leukemia CD34+ cells via p55 TNFα receptors. Blood, 84, 2506 2514.
  • 19
    Kobayashi, D., Watanabe, N., Yamauchi, N., Tsuji, N., Sato, T., Niitsu, Y. (1997) Endogenous tumor necrosis factor as a predictor of doxorubicin sensitivity in leukemic patients. Blood, 89, 2472 2479.
  • 20
    Kohno, T., Brewer, M.T., Baker, S.L., Schwartz, P.E., King, M.W., Hale, K.K., Squires, C.H., Thompson, R.C., Vannice, J.L. (1990) A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. Proceedings of the National Academy of Sciences of the United States of America, 87, 8331 8335.
  • 21
    Loetscher, H., Pan, Y.C., Lahm, H.W., Gentz, R., Brockhaus, M., Tabuchi, H., Lesslauer, W. (1990) Molecular cloning and expression of the human 55 Kd tumor necrosis factor receptor. Cell, 61, 351 359.
  • 22
    McHugh, S.M. & Rowland, T.L. (1997) Thalidomide and derivatives: immunological investigations of tumor necrosis factor-alpha (TNF-α) inhibition suggest drugs capable of selective gene regulation. Clinical and Experimental Immunology, 110, 151 154.
  • 23
    Oster, W., Cicco, N.A., Klein, H., Hirano, T., Kishimoto, T., Lindemann, A., Mertelsmann, R., Herrmann, F. (1989) Participation of the cytokines interleukin-6, tumor necrosis factor-alpha, and interleukin-1β secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control. Journal of Clinical Investigation, 84, 451 457.
  • 24
    Schall, T.J., Lewis, M., Koller, K.J., Lee, A., Rice, G.C., Wong, G.H.W., Gatanaga, T., Granger, G.A., Lentz, R., Raab, H., Kohr, W.J., Goeddel, D.V. (1990) Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell, 61, 361 370.
  • 25
    Smith, C.A., Davis, T., Anderson, D., Solam, L., Beckmann, M.P., Jerzy, R., Dower, S.K., Cosman, D., Goodwin, R.G. (1990) A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science, 248, 1019 1023.
  • 26
    Todeschini, G., Meneghini, V., Pizzolo, G., Cassibba, V., Ambrosetti, A., Veneri, D., Nadali, G., Zanotti, R., Tecchio, C., Perona, G. (1994) Daunorubicin dosage in induction phase is a major prognostic factor in long term results of adult acute lymphoblastic leukemia. Leukemia, 8, 376 381.
  • 27
    Todeschini, G., Tecchio, C., Meneghini, V., Pizzolo, G., Veneri, D., Zanotti, R., Ricetti, M., Solero, P., Aprili, F., Perona, G. (1998) Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin. Leukemia, 12, 144 149.
  • 28
    Trentin, L., Pizzolo, G., Zambello, R., Agostini, C., Morosato, L., Sancetta, R., Adami, F., Vinante, F., Chilosi, M., Gallati, H., Semenzato, G. (1995) Leukemic cells in hairy cell leukemia and B-cell chronic lymphocytic leukemia release soluble TNF receptors. Leukemia, 9, 1051 1055.
  • 29
    Van Den Heuvel-Eibrink, M.M., Van Der Holt, B., Boekhorst, P.A.W., Pieters, R., Schoester, M., Lowenberg, B., Sonneveld, P. (1997) MDR1 expression is an independent prognostic factor for response and survival in de novo acute myeloid leukaemia. British Journal of Haematology, 99, 76 83.
  • 30
    Vinante, F., Rigo, A., Tecchio, C., Patuzzo, C., Ricetti, M.M., Morosato, L., Cassatella, M.A., Chilosi, M., Pizzolo, G. (1996) Preferential release of high amounts of interleukin-8 by myeloid blasts showing monocytic differentiation. Haematologica, 81, 195 200.
  • 31
    Vinante, F., Rigo, A., Vincenzi, C., Ricetti, M.M., Marrocchella, R., Chilosi, M., Cassatella, M.A., Bonazzi, L., Pizzolo, G. (1993) IL-8 mRNA expression and IL-8 production by acute myeloid leukemia cells. Leukemia, 7, 1552 1556.